effects of proteases on membrane stability of red …
TRANSCRIPT
原 著 (Original Contribution) : 膜 (MEMBRANE), 20 (4), 287-295 (1995)
EFFECTS OF PROTEASES ON MEMBRANE
STABILITY OF RED BLOOD CELLS
Kaoru Nagao*•”, Yuichi Takakuwa*, Sumie Manno*
and Hidehiro Suzuki
Departments of *Biochemistry and #Anesthesiology , Tokyo Women's Medical College, 8-1 Kawada-cho, Shinjyuku-ku, Tokyo, 162, Japan
Skeletal proteins of red blood cells appear to be importantly involved in regulating the membrane
mechanical properties that arise with membrane deformability and stability. However, the effects of
limited digestion of skeletal proteins by proteases remain to be clearly determined. To clarify whether
proteases such as trypsin inhibitor-sensitive protease(s) and ƒÊ-calpain, a Ca2+-dependent neutral pro-
tease affect membrane mechanical properties through proteolysis of membrane proteins, assessment
was made of membrane stability of resealed ghosts treated with exogenous ƒÊ-calpain in the presence of
the Ca2+ and/or the trypsin inhibitor . Membrane proteins were analyzed by SDS-polyacrylamide gel
electrophoresis and immunobotting using antibodies against red cell membrane proteins. Untreated
ghosts showed decreased membrane stability and degradation of ankyrin . Inhibition of membrane-
associated protease activity by the trypsin inhibitor restored normal membrane stability and prevented
ankyrin degradation. When membranes previously treated with 4 U/ml of ii-calpain in the presence of
10ƒÊM Ca2+ at 0•Ž were resealed in the presence of trypsin inhibitor, membrane stability decreased and
only ankyrin was degradated, producing a polypeptide of 195-kD . With increase in calpain treatment
time, ankyrin decreased with increase in the 195-kD polypeptide . Correlation between membrane sta-
bility and calpain effects was demonstrated by increase in this polypeptide and decrease in membrane
stability. Elevation of cytosolic Ca2+ to more than 1 ƒÊM would thus appear to cause decrease in mem-
brane stability through Ca2+-activated limited digestion of ankyrin by ƒÊ -calpain .
Key words : red blood cell, protease, membrane stability, calpain, ankyrin
Introduction
Extensive deformation is required for red
cells to pass through small capillaries , and the membrane must be sufficiently strong
to withstand this distortion and resist shear-
induced membrane fragmentation. Such
mechanical stability of erythrocyte mem-
branes is maintained and regulated primar-
ily by the membrane skeleton consisting of
a network of structural proteins 1) . All ma-
jor erythrocyte membrane proteins are af-
fected by one or several types of post-trans-
lational modification 2). Post-translational
modification, such as proteolysis, may be
detrimental to protein functions including
protein-protein interactions on the mem-
brane skeleton. In red blood cells, several
types of proteases are present in membranes
and cytosol 3•`7) . The activity of membrane-
288 Nagao et al. : EFFECTS OF PROTEASES ON MEMBRANE STABILITY OF RED BLOOD CELLS
associated proteases was apparent from the
degradation of membrane proteins by en-
dogenous proteases during incubation of
isolated membranes. One such protease is
serine protease which is inhibited by soy-
bean trypsin inhibitor. In contrast to mem-
brane-associated proteases, most cytosolic
proteases are removed by extensive mem-
brane washing with a hypotonic buffer dur-
ing ghost preparation. Thus, to assess the
effects of cytosolic proteases on membrane
stability, each must be incorporated exoge-
nously into a ghost prior to resealing.
Calpain (EC 3.4.22.17) belongs to a family
of Ca2+-dependent neutral cysteine proteas-
es present in many different cells8- Most
mammalian cells contain two calpains : cal-
pain I or g-calpain, activated by micromolar
Ca2+ and calpain II or m-calpain, activated by
Ca2+ at millimolar concentration. Human
erythrocytes contain only ƒÊ-calpain 12, 13)
Most erythrocyte calpain is present in cy-
tosol as an inactive 80-kD proenzyme. In the
presence of micromolar Ca2f, procalpain
binds to membranes to be converted to the
active 75-kD form by autoproteolysis 14•`19)
Increased erythrocyte intracellular Ca2+
leads to calpain-induced degradation of var-
ious membrane proteins, most notably an-
kyrin and protein 4.120). Up to now, the ef-
fects of such degradation on membrane me-
chanical properties remain unclear.
To determine whether proteases such as
trypsin inhibitor sensitive protease(s) and ,ƒÊ-
c alp ain have effect on membrane stability,
we measured membrane stability of ghosts
treated with soybean-trypsin inhibitor and
exogeneous ,ƒÊ-calpain in the presence of Ca2+.
Inhibition of membrane-associated trypsin
inhibitor-sensitive protease activity by it's
inhibitor restored normal membrane stabil-
ity and prevented ankyrin degradation. ƒÊ-
Calpain treatment was shown to bring about
decrease in membrane stability with the de-
gradation of ankyrin and the production of
a 195-kD polypeptide.
1. Methods
1.1 Materials
μ-Ca1Dain and calpain inhibitor I were ob-
tamed from Suntory Co. Soybean trypsin in-
hibitor was purchased from Sigma Chemi-
cal Co. All were dialyzed against a hypoton-
ic buffer consisting of 5 mM Tris and 5 mM
KC1 (pH 7.4). Affinity-purified rabbit poly-
clonal antibodies against ankyrin and pro-
tein 4.1 were prepared by the usual meth-
ods21) .
1.2 Preparation of resealed ghosts
After obtaining informed consent, human
venous blood was drawn from healthy vol-
unteers (<25 years old) for use in subsequ-
ent experiments. White membranes were
prepared by lysing and washing human red
blood cells with the ice-cold hypotonic buf-
fer. For restoration of isotonicity, a small
volume of KC1, MgCl2 and dithiothreitol
(DTT) mixture was added to the membrane
suspension, to final concentrations of 150
mM KC1, 1 mM MgCl2 and 1 mM DTT. The
ghost suspension was incubated at 37•Ž for
40 min for ghosts resealing.
1.3 ƒÊ-Calpain treatment of membranes
For this purpose, white membranes were
incubated with 10 ƒÊM CaCl2 and 4 U/ml of
μ-calpain at O℃ for as much as 12 min. To
terminate calpain-catalyzed proteolysis, cal-
pain inhibitor I and EGTA were added to
final concentrations of 0.6 mg/m/ and 1 mM,
膜 (MEMBRNE), Vol. 20 No. 4 (1995) 289
respectively. The membranes were resealed
as described above.
1.4 Measurement of membrane stability
To measure membrane stability, resealed
ghosts were suspended in dextran (40,000 mol wt, 35%wt/vol) and examined by the
ektacytometer as described previously 22) . Briefly, suspended ghosts were subjected to
constant shear stress of 750 dyn/cm2 and
changes in laser diffraction patterns were
examined based on signal designated as the
deformability index (DI). Ghosts fragment
and resultant loss of membrane surface de-
creased DI with time. The rate at which DI
decreases is a measure of the rate of mem-
brane fragmentation, and hence, provides a
quantitative measure of membrane stabili-
ty. The time required for DI to reach half
its maximal value is designated T50 and was
used to evaluate changes in membrane sta-
bility.
1.5 Analysis of membrane proteins
Membrane proteins were analysed by so-
dium dodesylsulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) with a 7.5%
polyacrylamide gel according to Laemmlie
et al.2, 3) and stained with Coomassie Bril-
liant Blue (CBB). Immunoblot analysis was
conducted with affinity-purified polyclonal
antibodies against ankyrin and protein 4 .1. Membrane proteins separated on SDS-PA
GE polyacrylamide gels were also blotted
on PVDF membranes using semi-dry trans-
blots (Nihon Eido Co)24) . Briefly, electro-
transfer of the proteins was carried out in 25
mM Tris containing 20% methanol and 40
Figure 1. SDS-PAGE analysis of ghosts treated with g-calpain in the presence and absence of tryp-
sin inhibitor
Membrane proteins of ghosts were analysed by SDS-PAGE in a 7.5% Laemmlie polyacry-
lamide gel and stained with CBB (lane 1) . Immunoblot analysis was performed with rabbit
antibodies against human ankyrin (lanes 2•`6) and protein 4 .1 (lanes 7•`9).
Lane 1 : unsealed membrane ; Lane 2 : unsealed membrane treated with calpain inhibitor I
followed by digestion with 4 U/ml calpain at 0•Ž for 12 min ; Lane 3 : unsealed membrane
digested with ƒÊ-calpain at 0•Ž for 12 min ; Lanes 4 and 7 : resealed ghosts ; Lanes 5 and 8 :
ghosts resealed in the presence of trypsin inhibitor ; Lanes 6 and 9 : resealed ghost treated
with ƒÊ-calpain in the presence of the trypsin inhibitor.
290 Nagao et al. : EFFECTS OF PROTEASES ON MEMBRANE STABILITY OF RED BLOOD CELLS
mM E-amino-n-Caproic acid for 1 h at 250
mA. The membranes were washed once in
0.2% Tween 20 and blocked with skim-milk
solution (Block-Ace, Yukijirushi Co) for 1
h, followed by incubation for 1 h at room
temperature with anti-ankyrin and anti pro-
tein 4.1 in skim-milk solution. Antigen-an-
tibody complexes were developed using the
peroxidase conjugate substrate kit of Dupon/ NEN. Briefly, the immunoblots were incu-
bated at room temperature for 1 h with an-
ti-rabbit IgG conjugated peroxidase and de-
veloped using the substrate solution of a
chemiluminescence reagent kit. The mem-
branes were exposed to Kodak X-ray film.
To determine the amounts of proteins, chem-
iluminescence profiles were analyzed with a
densitometer (ATTO AE6,900M). Protein
concentration was determined according to
the method of Lowry et al.2 5)
2. Results
2.1 Immunoblot analysis of red cell mem-
brane proteins digested with proteases.
Red cell membrane proteins digested with
membrane-associated protease(s) and ii -
calpain were analyzed by SDS-PAGE and
immunoblotting using antibodies against
ankyrin and protein 4.1 (Fig. 1). Immuno-
blot analysis of calpain-untreated mem-
branes showed most ankyrin to appear as
the 210-kD polypeptide with a minor band of
200-kD (Fig. 1, lane 2). Ankyrin on unsealed
membranes apparently underwent digestion
by 4 U/m/ of i-calpain at 0•Ž for 12 min to
produce a 195-kD band (Fig. 1, lane 3). A
200-kD band diminished by g-calpain. When
the calpain-untreated membranes were in-
cubated for ghost resealing at 37•Ž for 40
min, ankyrin was digested with consequent
production of the 195-kD polypeptide as well
as several small fragments (Fig. 1, lane 4).
Presence of soybean trypsin inhibitor dur-
ing incubation at 37•Ž for 40 min prevented
ankyrin degradation (Fig. 1, lane 5). How-
ever, calpain-induced degradation of anky-
rin was unaffected by the trypsin inhibitor
or incubation of membranes at 37•Ž for 40
min (compare Fig. 1, lanes 3 and 6). Im-
munoblot analysis indicated protein 4.1 not
to be affected by the trypsin inhibitor or
calpain (Fig. 1, lanes7-9). All major prote-
ins except ankyrin were apparently not affect-
ed on the SDS-PAGE gel (data not shown).
2. 2 Effects of 1.1 -calpain on membrane
stability.
Ghost resealing in the presence of the tryp-
sin inhibitor prevented decrease in mem-
brane stability. Calpain treatment decreas-
ed membrane stability. Typical changes in
Figure 2. Membrane stability of ghosts Under high constant shear stress of 750 dyn/ cm2, untreated ghosts (line b) began to frag-ment at 10 sec and the T50 was 18 sec. Ghosts resealed in the presence of trypsin inhibitor
(line a) began to fragment at 15 sec and T50 was 30 sec. Ghosts treated with ,u-calpain in the presence ofthe trypsine inhibitor (line c) fragmented in a manner similar to that noted for untreated ghosts.
膜(MEMBRNE),Vol. 20 No. 4 (1995) 291
A B
C
DI are shown in Fig. 2. When resealed ghosts
were subjected to an applied shear stress of
750 dyn/cm2, membrane fragmentation oc-
curred for a certain period of time. For com-
parative assessment of membrane stability, T50 was determined. For calpain-untreated
ghosts resealed in the presence and absence of the trypsin inhibitor, T 50 was 30 and 18
sec, respectively. For calpain-treated ghosts
resealed in the presence of the trypsin in-
hibitor, T 50 was 16 sec. When membranes
previously treated with calpain together with calpain inhibitor I were resealed in the pres-
ence of the trypsin inhibitor, the ghosts frag-
mented in a manner similar to that of the
calpain-untreated ghosts resealed in the
presence of this inhibitor (data not shown).
The presence of 10 ,a1VI Ca2+ alone or the cal-
pain inhibitor alone failed to alter stability
(data not shown). It follows from these re-sults that the trypsin inhibitor restores mem-
brane stability and that calpain activation
Figure 3. Degradation of ankyrin and pro-
tein 4.1 by g-calpain treatment
Unsealed membranes were treated
with g-calpain for 0 to 12 min, fol-
lowed by incubation at 37•Ž for 4C
min in the presence of trypsin in-
hibitor. Immunoblot analysis of
these resealed ghosts were carried
out with antibodies against (A)
ankyrin and (B) protein 4.1. (C)
Density of the 195-kD polypeptide
(●)andprotein4.1(○)wereplot-
tedagainstcalpaintreatmenttime.
292 Nagao et al. : EFFECTS OF PROTEASES ON MEMBRANE STABILITY OF RED BLOOD CELLS
lessens membrane stability. The addition of
μ-calpain to the outside of ghosts after re-
sealing did not alter membrane stability
(data not shown). The effects of g-calpain on membrane stability would thus appear
due to its effects on the cytoplasmic side of
the membrane.
2.3 Time dependent degradation of an-
kyrin by p-calpain treatment
To monitor the time-dependent degrada-
tion of ghost membrane proteins by g-cal-
pain treatment, immunoblotting using anti-
bodies against ankyrin and protein 4.1 was
performed (Fig. 3). Ankyrin on ghost mem-branes was clearly digested by 4 U/ml of
μ-calpain at 0℃ with time, with consequent
increaseintheamountofthe195-kDpoly-
peptide(Fig.3A).Thephotographicdensity
of the 195-kD band was plotted against ,a-
calpain incubation time (Fig. 3C). Analysis
with immunoblotting showed protein 4.1 not
to be affected by g-calpain treatment (Fig.
3BC). g-Calpain treatment under the pre-
sent conditions thus brings about the degra-
dation of only ankyrin.
2. 4 Correlation between membrane sta-
bility and formation of the 195-kD polypep-
tide.
Membrane stability of ghosts decreased
with increase in g-calpain incubation time
(data not shown). In Fig. 4, T 50 is plotted
against the photographic density of the 195-
kD band obtained from Fig. 3C. This plot
clearly shows decrease in membrane stabili-
ty can be seen to be correlated with increase
in the 195-kD polypeptide and hence, with
decrease in ankyrin.
3. Discussion
The present study demonstrates for the
first time that g-calpain catalyzes the limit-
ed digestion of ankyrin on erythrocyte mem-
branes, with consequent decrease in mem-
brane stability.
For measurement of membrane stability,
resealed ghosts were prepared by membrane
incubation at 37•Ž for 40 min. Under these
conditions, ankyrin on the membranes was
clearly degradated by membrane-associa-
ted protease(s) to produce several peptides
with the molecular weight of 195-kD or less.
The digestion of ankyrin was prevented by
the presence of the soybean trypsin inhibitor,
indicating trypsin-inhibitor sensitive pro-
tease(s) to be present on erythrocyte mem-
branes. From these results, it follows that
the trypsin inhibitor may be used in all cas-
es for assessing g-calpain effects on the de-
Figure 4. Correlation between membrane
stability and amounts of 195-kD
polypeptide. T 50 is plotted against the photo-
graphic density of 195-kD polypep-tide. T50 for ghosts resealed in the
presence of the trypsin inhibitor
was normalized to 100%. Increases
in the amounts of this polypeptide
decreased T50.
膜 (MEMBRNE), Vol. 20 No. 4 (1995) 293
gradation of membrane proteins and mem-
brane stability.
When membranes treated with 4 U/m/ ex-
ogenous IL -calpain in the presence of 10 gM
Ca2+ at 0•Ž for 12 min were incubated in the
resealing buffer containing the trypsin in-
hibitor, only ankyrin was degradated, pro-
ducing the 195 kDa polypeptide. This find-
ing is basically consistent with the previous
report showing digestion of purified ankyrin
by ,u-calpain to produce many fragments in-
cluding this polypeptide26' . It is important
to note that ankyrin on membranes produces
the 195-kD polypeptide without further de-
gradation by ,u -calpain. This polypeptide
differs from the 195-kD product of ankyrin
digestion by trypsin inhibitor-sensitive ser-
ine protease(s), since g-calpain is a cysteine
protease which removes the last 196 amino
acids from the C-terminus of ankyrin to pro-
duce the 195-kD polypeptide24) . This poly-
peptide was previously shown to bind to an-
kyrin-depleted inside-out vesicles with eight-
fold reduction in affinity but with binding
capacity twice that of undigested ankyrin 2 4) .
μ-Calpain can also remove 119 amino acids
from the C-terminus of ankyrin, possibly
producing the 200-kD polypeptide, based on
the results of immunoblot analysis.
It should be pointed out that spectrin, pro-
tein 4.1, and band 3 on membranes may not
necessarily undergo degradation by exoge-
nous ,a-calpain. However, purified erythro-
cyte spectrin a and ,6 chains are readily di-
gested by calpain, as are also purified an-kyrin and protein 4.126' . Band 3 has been
shown to be degradated in g-calpain-treated.
ghosts prepared from red blood cells of el-
derly people (>70 years old) 2 7) . However, in
the present study, fresh human venous blood
from healthy young volunteers was used
(<25 years old).
Membrane stability is essential for the
passage of red blood cells to pass through
small capillaries without fragmentation un-
der shear stress. The membrane skeleton
may be the means for maintaining mem-
brane stability. Most data in this regard in-
dicate lateral interactions such as spectrin
dimer association and spectrin-protein 4.1-
actin association rather than vertical inter-
actions such as band 3-ankyrin-i3-spectrin
association and glycophorin-protein 4.1 as-
sociation. Alteration in the binding of anky-
rin to band 3 may be the cause for changes
in membrane mechanical properties. The
artificial dissociation of band 3 and ankyrin
is induced by certain sulfhydryl reagents2 8) ,
competing antibodies29' and elevation in pH
to near 930). Low et al. have shown eleva-
tion in intracellular pH above 8.5 to gradu-
ally release band 3 from ankyrin and mem-
branes to become unstable 31) . They hypoth-
esize that the ankyrin-band 3 linkage of the
membrane skeleton with the lipid bilayer is
essential for maintaining red blood cell sta-
bility. However, the high pH in their study
may have affected the chemical nature and
interactions of membrane lipids and pro-
teins as well as cell shape32) . In this study,
erythrocyte membranes were treated with it-
calpain under physiological pH and degra-
dation of ankyrin resulted in decreased
membrane stability. Production of the 195-
kD polypeptide may have been the cause for
this decrease by reducing affinity for bind-
ing to membranes2 6) . This would confirm
Low's report that membrane stability de-
creases through alteration of the band 3-an-
kyrin-ƒÀ-spectrin linkage.
That Ca2+ at more than 1 M was found
in this study to induce decrease in mem-
294 Nagao et al. : EFFECTS OF PROTEASES ON MEMBRANE STABILITY OF RED BLOOD CELLS
brane stability by Ca2+ activation of ,u-cal-
pain implies that, for red blood cells to main-
tain normal membrane stability, intracellu-
lar Ca2+ must be less than 1ƒÊM. The re-
markably efficient Ca2+-ATPase system is
able to maintain such a concentration in nor-
mal red cells33, 34) . Failure to maintain low
normal intracellular Ca2+ has been docu-
mented in abnormal cells such as sickle and
thalassemic cells as well as senescent
cells35•`40) In these cells, Ca2+-dependent
functions, such as those of Ca2+-dependent
protein kinase C, the Ca2+-calmodulin com-
plex and calpain become active. Protein ki-
nase C phosphorylates protein 4.1, band 4.9
(or dematin) and adducin in the presence of
micromolar Ca2+ 41•`43) However, little is
known about the effects of the phosphoryla-
tion of these proteins on membrane mechan-
ical properties. Membrane stability has been
shown to decrease with increasing Ca2+ con-
centration at more than 1ƒÊM in the pres-
ence of calmodulin 44) . In contrast to revers-
ible Ca2+-dependent functions, Ca2+ higher
than 1ƒÊM is shown by the present study to
also activate ƒÊ-calpain which irreversibly
catalyzes the proteolysis of ankyrin, with
consequent decrease in membrane stability.
This irreversible process may be part of the
mechanism for the limited life span of red
blood cells.
References
1) N. Mohandas, J. A. Chasis, and S. B. Sho-
het, Semin. Hematol., 20, 225 (1983)
2) C. M. Cohen and P. Gascard, Semin. Hema-
tol., 29, 244 (1992)
3) Z. A. Tokes and A. M. Chambers, Biochim.
Biophys. Acta., 389, 325 (1975)
4) S. K. Ballas and E. R. Burka, Blood, 53, 875
(1979) 5) D. L. Siegel, S. R. Goodman, and D. Branton,
Biochim. Biophys. Acta, 598, 517 (1980)
6) J. Chao, L. Chao, and H. S. Margolius, Bio-
chem. Biophys. Res. Gomm,un., 121, 722 (1984)
7) M. Gaczynska, G. Bartosz, J. Rosin, and M.
Soszynski, Comp. Biochem. Physiol., 91B,
617 (1988)
8) R. L. Mellgren, FASEB J., 1, 110 (1987)
9) E. Melloni and S. Pontremoli, TINS, 12, 438
(1989)10) D. E. Croall and G. N. Demartino, Physiol.
Rev., 71, 813 (1991)11) T. C. Saido, H. Sorimachi, and K. Suzuki,
FASEB J., 8, 814 (1994)
12) T. Murakami, M. Hatanaka, and T. Mura-
chi, J. Biochem., 90, 1809 (1981)
13) M. Hatanaka, T. Kikuchi, and T. Murachi,
Biomed. Res., 4, 381 (1983)
14) S. Pontremoli, E. Melloni, B. Sparatore, F.
Salamino, M. Michetti, O. Sacco, and B. L.
Horecker, Biochem. Biophys. Res. Commun., 128, 331 (1985)
15) S. Pontremoli, F. Salamino, B. Sparatore,
M. Michetti, 0. Sacco, and E. Melloni, Bio-
chim. Biophys. Acta, 831, 335 (1985)16) M. Grasso, A. Morelli, and A. De Flora. Bio-
chem. Biophys. Res. Commun., 138, 87 (1986)
17) S. Imajo, H. Kawasaki, and K. Suzuki, J.
Biochem. (Tokyo), 100, 633 (1986)
18) W. J. Lee, Y. Adachi, M. Maki, et al., Bio-
chem. Int., 22, 163 (1990)19) M. Inomata, M. Hayashi, M. Nakamura, Y.
Saito, and S. Kawashima, J. Biol. Chem., 264, 18838 (1989)
20) Y. Takakuwa, G. Tchemia, M. Rossi, M. Ben-
abadji, and N. Mohandas, J. Clin. Invest.,
78, 80 (1986)
21) P. Boivin, C. Galand, and D. Dhermy, Int. J.
Biochem., 22, 1479 (1990)22) N. Mohandas, M. R. Clark, B. P. Heath, M.
Rossi, L. C. Wolfe, S. E. Lux, and S. B. Sho-
het, Blood, 59, 768 (1982)
23) U.K. Laemmli, Nature, 227, 680 (1970)
24) S. Manno, Y. Takakuwa, K. Nagao, and N.
Mohandas, J. Biol. Chem., 270, 5659 (1995)
25) O. H. Lowry, N. J. Rosebrough, A. L. Farr,
and R. J. Randall, J. Biol. Chem., 193, 265
(1951)
膜(MEMBRNE), Vol. 20 No. 4 (1995) 295
26) T. G. Hall and V. Bennett, J. Biol. Chem.,
262, 10537 (1987)
27) N. S. B. Meir, T.Glaser, and N. S. Kosower,
Biochem. J. , 275, 47 (1991)
28) B. J. M. Thevenin, B. M. Willardson, and P.
S. Low, J. Biol. Chem., 264, 15886 (1989)
29) B. M. Willardson, B. J. M. Tevenin, M. L.
Harrison, W. M. Kuster, M. D. Benson, and
P. S. Low, J. Biol. Chem., 264, 15893 (1989)
30) P. S. Low, M. A. Westfall, D. P. Allen, and
K. C. Appell, J. Biol. Chem., 259, 13070 (1984)
31) P. S. Low, B. M. Willardson, N. Mohandas,M. Rossi, and S. B. Shohet, Blood, 77, 1581
(1991)32) V. Bennett and P. J. Stenbuck, J. Biol. Chem.,
255, 6424 (1980)
33) H. J. Schatzman, Curr. Top. Membr. Transp.,
6, 125 (1975)
34) V. L. Lew, R. Y. Tsien, and C. Miner, Nature
(Lond.), 298, 478 (1982)35) T. Shiga, N. Maeda, T. Suda, K. Kon, and M.
Sekiya, Biochim. Biophys. Acta, 553, 84 (1979)
36) G. B. Nash and H. J. Meiselman, Microcir-
culation, 1, 255 (1981)
37) J. W. Eaton, T. D. Skeleton, H. S. Swofford, C.E. Kolpin, and H. S. Jacob, Nature (Lond.),
246, 105 (1973)
38) 0. Shalev, S. Mogilner, E. Shinar, E. A. Rach-
milewitz, and S. L. Schrier, Blood, 64, 564
(1984)39) V. L. Lew, A. Hockaday, M. I. Sepulveda, A.
P. Somlyo, A. V. Somlyo, 0. E. Ortiz, and
R. M. Bookchin, Nature (Lond. ), 315, 586
(1985)40) T. Shiga, M. Sekiya, N. Maeda, K. Kon, and
M. Okazaki, Biochim. Biophys. Acta, 814, 289
(1985)41) E. Ling and V. Sapirstein, Biochem. Bio-
phys. Res. Commun. , 120, 291 (1984) 42) W. C. Faquin, S. B. Chahwala, L. C. Cant-
ley, and D. Branton, Biochim. Biophys. Ac-
ta., 887, 142 (1986)
43) C. M. Cohen and S. F. Foley, J. Biol. Chem.,
261, 7701 (1986)
44) Y. Takakuwa and N. Mohandas, J. Clin. In-
vest., 82, 394 (1988)
(受付1995年1月19日)